Skip to main content
Erschienen in: Virchows Archiv 2/2014

01.02.2014 | Original Article

Oil Red O-assessed macrosteatosis in liver transplant donor biopsies predicts ischemia–reperfusion injury and clinical outcome

Erschienen in: Virchows Archiv | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Abstract

Steatosis in donor livers is an accepted adverse prognostic factor after liver transplantation. While its semiquantitative assessment shows varying reproducibility, it is questioned as a standard method. Additionally, the influence of hepatic steatosis on ischemia/reperfusion injury (I/R injury) has not been evaluated in biopsies after reperfusion. We compared different staining and analyzing methods for the assessment of donor liver steatosis in order to predict I/R injury and clinical outcome after transplantation. To do this, 56 paired pre- and post-reperfusion liver biopsies were analyzed for macro- (MaS)/micro- (MiS) and total steatosis in cryo and permanent sections by special fat (Oil Red O or ORO) and standard stains. Computerized morphometrical analyses were compared to the semiquantitative assessment by a pathologist. I/R injury was determined histopathologically and by M30 immunohistochemistry. We found ORO to be more sensitive in detecting hepatic steatosis with higher reproducibility for MaS. Semiquantitative analyses were highly reproducible and not inferior to computerized morphometry. Categorized MaS as determined by ORO correlated with the extent of I/R injury, initial poor function, liver enzymes, and survival. Therefore fat stains like ORO are a reliable and easy method comprising significant advantages in the evaluation of hepatic steatosis and are thereby of prognostic value. Computerized analysis is a precise tool though not superior to semiquantitative analyses.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Soejima Y, Shimada M, Suehiro T, Kishikawa K, Yoshizumi T, Hashimoto K, Minagawa R, Hiroshige S, Terashi T, Ninomiya M, Shiotani S, Harada N, Sugimachi K (2003) Use of steatotic graft in living-donor liver transplantation. Transplantation 76(2):344–348. doi:10.1097/01.TP.0000071205.52835.A4 PubMedCrossRef Soejima Y, Shimada M, Suehiro T, Kishikawa K, Yoshizumi T, Hashimoto K, Minagawa R, Hiroshige S, Terashi T, Ninomiya M, Shiotani S, Harada N, Sugimachi K (2003) Use of steatotic graft in living-donor liver transplantation. Transplantation 76(2):344–348. doi:10.​1097/​01.​TP.​0000071205.​52835.​A4 PubMedCrossRef
2.
Zurück zum Zitat Sotiropoulos GC, Paul A, Molmenti E, Lang H, Frilling A, Napieralski BP, Nadalin S, Treckmann J, Brokalaki EI, Gerling T, Broelsch CE, Malago M (2005) Liver transplantation for hepatocellular carcinoma in cirrhosis within the Eurotransplant area: an additional option with "livers that nobody wants". Transplantation 80(7):897–902PubMedCrossRef Sotiropoulos GC, Paul A, Molmenti E, Lang H, Frilling A, Napieralski BP, Nadalin S, Treckmann J, Brokalaki EI, Gerling T, Broelsch CE, Malago M (2005) Liver transplantation for hepatocellular carcinoma in cirrhosis within the Eurotransplant area: an additional option with "livers that nobody wants". Transplantation 80(7):897–902PubMedCrossRef
4.
Zurück zum Zitat Sotiropoulos GC, Paul A, Gerling T, Molmenti EP, Nadalin S, Napieralski BP, Treckmann J, Lang H, Saner F, Frilling A, Broelsch CE, Malago M (2006) Liver transplantation with "rescue organ offers" within the Eurotransplant area: a 2-year report from the University Hospital Essen. Transplantation 82(3):304–309. doi:10.1097/01.tp.0000229447.37333.ed PubMedCrossRef Sotiropoulos GC, Paul A, Gerling T, Molmenti EP, Nadalin S, Napieralski BP, Treckmann J, Lang H, Saner F, Frilling A, Broelsch CE, Malago M (2006) Liver transplantation with "rescue organ offers" within the Eurotransplant area: a 2-year report from the University Hospital Essen. Transplantation 82(3):304–309. doi:10.​1097/​01.​tp.​0000229447.​37333.​ed PubMedCrossRef
6.
Zurück zum Zitat Fiorentino M, Vasuri F, Ravaioli M, Ridolfi L, Grigioni WF, Pinna AD, D'Errico-Grigioni A (2009) Predictive value of frozen-section analysis in the histological assessment of steatosis before liver transplantation. Liver Transpl 15(12):1821–1825. doi:10.1002/lt.21948 PubMedCrossRef Fiorentino M, Vasuri F, Ravaioli M, Ridolfi L, Grigioni WF, Pinna AD, D'Errico-Grigioni A (2009) Predictive value of frozen-section analysis in the histological assessment of steatosis before liver transplantation. Liver Transpl 15(12):1821–1825. doi:10.​1002/​lt.​21948 PubMedCrossRef
7.
Zurück zum Zitat Lo IJ, Lefkowitch JH, Feirt N, Alkofer B, Kin C, Samstein B, Guarrera JV, Renz JF (2008) Utility of liver allograft biopsy obtained at procurement. Liver Transpl 14(5):639–646. doi:10.1002/lt.21419 PubMedCrossRef Lo IJ, Lefkowitch JH, Feirt N, Alkofer B, Kin C, Samstein B, Guarrera JV, Renz JF (2008) Utility of liver allograft biopsy obtained at procurement. Liver Transpl 14(5):639–646. doi:10.​1002/​lt.​21419 PubMedCrossRef
9.
Zurück zum Zitat Yoong KF, Gunson BK, Neil DA, Mirza DF, Mayer AD, Buckels JA, McMaster P (1999) Impact of donor liver microvesicular steatosis on the outcome of liver retransplantation. Transplant Proc 31(1–2):550–551PubMedCrossRef Yoong KF, Gunson BK, Neil DA, Mirza DF, Mayer AD, Buckels JA, McMaster P (1999) Impact of donor liver microvesicular steatosis on the outcome of liver retransplantation. Transplant Proc 31(1–2):550–551PubMedCrossRef
10.
Zurück zum Zitat Fishbein TM, Fiel MI, Emre S, Cubukcu O, Guy SR, Schwartz ME, Miller CM, Sheiner PA (1997) Use of livers with microvesicular fat safely expands the donor pool. Transplantation 64(2):248–251PubMedCrossRef Fishbein TM, Fiel MI, Emre S, Cubukcu O, Guy SR, Schwartz ME, Miller CM, Sheiner PA (1997) Use of livers with microvesicular fat safely expands the donor pool. Transplantation 64(2):248–251PubMedCrossRef
11.
Zurück zum Zitat Urena MA, Ruiz-Delgado FC, Gonzalez EM, Segurola CL, Romero CJ, Garcia IG, Gonzalez-Pinto I, Gomez Sanz R (1998) Assessing risk of the use of livers with macro and microsteatosis in a liver transplant program. Transplant Proc 30(7):3288–3291PubMedCrossRef Urena MA, Ruiz-Delgado FC, Gonzalez EM, Segurola CL, Romero CJ, Garcia IG, Gonzalez-Pinto I, Gomez Sanz R (1998) Assessing risk of the use of livers with macro and microsteatosis in a liver transplant program. Transplant Proc 30(7):3288–3291PubMedCrossRef
12.
13.
Zurück zum Zitat El-Badry AM, Breitenstein S, Jochum W, Washington K, Paradis V, Rubbia-Brandt L, Puhan MA, Slankamenac K, Graf R, Clavien PA (2009) Assessment of hepatic steatosis by expert pathologists: the end of a gold standard. Ann Surg 250(5):691–697. doi:10.1097/SLA.0b013e3181bcd6dd PubMedCrossRef El-Badry AM, Breitenstein S, Jochum W, Washington K, Paradis V, Rubbia-Brandt L, Puhan MA, Slankamenac K, Graf R, Clavien PA (2009) Assessment of hepatic steatosis by expert pathologists: the end of a gold standard. Ann Surg 250(5):691–697. doi:10.​1097/​SLA.​0b013e3181bcd6dd​ PubMedCrossRef
14.
Zurück zum Zitat Nanashima A, Pillay P, Verran DJ, Painter D, Nakasuji M, Crawford M, Shi L, Ross AG (2002) Analysis of initial poor graft function after orthotopic liver transplantation: experience of an Australian single liver transplantation center. Transplant Proc 34(4):1231–1235PubMedCrossRef Nanashima A, Pillay P, Verran DJ, Painter D, Nakasuji M, Crawford M, Shi L, Ross AG (2002) Analysis of initial poor graft function after orthotopic liver transplantation: experience of an Australian single liver transplantation center. Transplant Proc 34(4):1231–1235PubMedCrossRef
15.
Zurück zum Zitat Ploeg RJ, D'Alessandro AM, Knechtle SJ, Stegall MD, Pirsch JD, Hoffmann RM, Sasaki T, Sollinger HW, Belzer FO, Kalayoglu M (1993) Risk factors for primary dysfunction after liver transplantation—a multivariate analysis. Transplantation 55(4):807–813PubMedCrossRef Ploeg RJ, D'Alessandro AM, Knechtle SJ, Stegall MD, Pirsch JD, Hoffmann RM, Sasaki T, Sollinger HW, Belzer FO, Kalayoglu M (1993) Risk factors for primary dysfunction after liver transplantation—a multivariate analysis. Transplantation 55(4):807–813PubMedCrossRef
21.
Zurück zum Zitat Markin RS, Wisecarver JL, Radio SJ, Stratta RJ, Langnas AN, Hirst K, Shaw BW Jr (1993) Frozen section evaluation of donor livers before transplantation. Transplantation 56(6):1403–1409PubMedCrossRef Markin RS, Wisecarver JL, Radio SJ, Stratta RJ, Langnas AN, Hirst K, Shaw BW Jr (1993) Frozen section evaluation of donor livers before transplantation. Transplantation 56(6):1403–1409PubMedCrossRef
22.
23.
Zurück zum Zitat Straub BK, Gyoengyoesi B, Koenig M, Hashani M, Pawella LM, Herpel E, Mueller W, Macher-Goeppinger S, Heid H, Schirmacher P (2013) Adipophilin/perilipin-2 as a lipid droplet-specific marker for metabolically active cells and diseases associated with metabolic dysregulation. Histopathology 62(4):617–631. doi:10.1111/his.12038 PubMedCrossRef Straub BK, Gyoengyoesi B, Koenig M, Hashani M, Pawella LM, Herpel E, Mueller W, Macher-Goeppinger S, Heid H, Schirmacher P (2013) Adipophilin/perilipin-2 as a lipid droplet-specific marker for metabolically active cells and diseases associated with metabolic dysregulation. Histopathology 62(4):617–631. doi:10.​1111/​his.​12038 PubMedCrossRef
25.
Zurück zum Zitat Iwasaki M, Takada Y, Hayashi M, Minamiguchi S, Haga H, Maetani Y, Fujii K, Kiuchi T, Tanaka K (2004) Noninvasive evaluation of graft steatosis in living donor liver transplantation. Transplantation 78(10):1501–1505PubMedCrossRef Iwasaki M, Takada Y, Hayashi M, Minamiguchi S, Haga H, Maetani Y, Fujii K, Kiuchi T, Tanaka K (2004) Noninvasive evaluation of graft steatosis in living donor liver transplantation. Transplantation 78(10):1501–1505PubMedCrossRef
26.
Zurück zum Zitat Heuer M, Kaiser GM, Kahraman A, Banysch M, Saner FH, Mathe Z, Gerken G, Paul A, Canbay A, Treckmann JW (2012) Liver transplantation in nonalcoholic steatohepatitis is associated with high mortality and post-transplant complications: a single-center experience. Digestion 86(2):107–113. doi:10.1159/000339344 PubMedCrossRef Heuer M, Kaiser GM, Kahraman A, Banysch M, Saner FH, Mathe Z, Gerken G, Paul A, Canbay A, Treckmann JW (2012) Liver transplantation in nonalcoholic steatohepatitis is associated with high mortality and post-transplant complications: a single-center experience. Digestion 86(2):107–113. doi:10.​1159/​000339344 PubMedCrossRef
Metadaten
Titel
Oil Red O-assessed macrosteatosis in liver transplant donor biopsies predicts ischemia–reperfusion injury and clinical outcome
Publikationsdatum
01.02.2014
Erschienen in
Virchows Archiv / Ausgabe 2/2014
Print ISSN: 0945-6317
Elektronische ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-013-1512-3

Weitere Artikel der Ausgabe 2/2014

Virchows Archiv 2/2014 Zur Ausgabe

Neu im Fachgebiet Pathologie

Open Access 15.04.2024 | Biomarker | Schwerpunkt: Next Generation Pathology

Molekularpathologische Untersuchungen im Wandel der Zeit

11.04.2024 | Pathologie | Schwerpunkt: Next Generation Pathology

Vergleichende Pathologie in der onkologischen Forschung

Open Access 08.04.2024 | GIST | CME

Gastrointestinale Stromatumoren

Wo stehen wir?

03.04.2024 | Zielgerichtete Therapie | Schwerpunkt: Next Generation Pathology

Personalisierte Medizin in der Onkologie